(Q38821051)

6 September 2017

title

PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis (English)

1 reference

6 September 2017

0 references

Cheng Zhang

1

1 reference

6 September 2017

Wei Tian

2

1 reference

6 September 2017

Lin Meng

3

1 reference

6 September 2017

Like Qu

4

1 reference

6 September 2017

Chengchao Shou

5

1 reference

6 September 2017

publication date

9 November 2015

1 reference

Journal of Molecular Medicine

6 September 2017

published in

1 reference

6 September 2017

volume

94

1 reference

6 September 2017

issue

4

1 reference

6 September 2017

page(s)

401-415

1 reference

PRL PTPs: mediators and markers of cancer progression

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Src-mediated phosphorylation of the tyrosine phosphatase PRL-3 is required for PRL-3 promotion of Rho activation, motility and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

PRL-3 activates NF-κB signaling pathway by interacting with RAP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Radiation promotes malignant progression of glioma cells through HIF-1alpha stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Hypoxia inducible factor (HIF)-1α directly activates leptin receptor (Ob-R) in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

MicroRNA-210: a unique and pleiotropic hypoxamir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

miR-210: the master hypoxamir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

MiR-210 disturbs mitotic progression through regulating a group of mitosis-related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

HypoxamiRs and cancer: from biology to targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Phosphatase of regenerating liver-3 directly interacts with integrin β1 and regulates its phosphorylation at tyrosine 783

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

The human side of hypoxia-inducible factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

PRL‐3 phosphatase and cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Hypoxia-inducible factors in physiology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Transcriptional upregulation of HIF-1α by NF-κB/p65 and its associations with β-catenin/p300 complexes in endometrial carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Regulation of hypoxia-inducible factor-1alpha by NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

microRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-κB1 in murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

PRL-3: a metastasis-associated phosphatase in search of a function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1350-7

High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study

21 January 2018

1 reference

12 December 2020

2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2

1 reference

12 December 2020

Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis

1 reference

12 December 2020

Targeting intracellular oncoproteins with antibody therapy or vaccination

1 reference

12 December 2020

HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells

1 reference

12 December 2020

The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison

1 reference

12 December 2020

10.1007/S00109-015-1350-7

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1015928073

0 references

1 reference